Homes England, the government’s national housing agency, has submitted an outline planning application proposing up to 4,000 homes as part of phase 3A of Northstowe.

The ability to raise financing during challenging times of a global pandemic demonstrates investor belief in the company and further evidence of the excellent progress the company has made in creating innovative antibodies against a range of important conditions.

Debbi Lynn, Matron, alongside Amber Coogan, Jenna Ridout, Emma May Chitty (pictured), Kelly Willett, Nina Dempsey, Aimee Tyrrell and Yasmin Farquhar, Clinical Nurse Specialists, who are part of EACH’s Symptom Management Nursing Service and have worked at the charity for 26 years between

As hyperscale providers build data centers with an expanding fleet to meet worldwide demand, the complexities to operate and maintain these facilities are creating an unprecedented set of challenges.  Operating at this scale requires a different approach for mission critical facilities powering t

Alison joins the firm from Fieldfisher where she has led the life sciences group and sat on their Executive Committee for a number of years.

Looking for something specific?

Homes England, the government’s national housing agency, has submitted an outline planning application proposing up to 4,000 homes as part of phase 3A of Northstowe.

The ability to raise financing during challenging times of a global pandemic demonstrates investor belief in the company and further evidence of the excellent progress the company has made in creating innovative antibodies against a range of important conditions.

Debbi Lynn, Matron, alongside Amber Coogan, Jenna Ridout, Emma May Chitty (pictured), Kelly Willett, Nina Dempsey, Aimee Tyrrell and Yasmin Farquhar, Clinical Nurse Specialists, who are part of EACH’s Symptom Management Nursing Service and have worked at the charity for 26 years between

As hyperscale providers build data centers with an expanding fleet to meet worldwide demand, the complexities to operate and maintain these facilities are creating an unprecedented set of challenges.  Operating at this scale requires a different approach for mission critical facilities powering t

Alison joins the firm from Fieldfisher where she has led the life sciences group and sat on their Executive Committee for a number of years.